None

Menopause Symptoms May Return After Escitalopram Stopped

Hot flashes and night sweats can return after women stop using escitalopram - an antidepressant - to treat these menopause symptoms, according to a study published online this month in Menopause, the...

Antidepressant Escitalopram Helps Heart Problem Caused By Stress

Researchers at Duke Medicine have revealed that a commonly prescribed antidepressant - escitalopram (Lexapro) - could be used to treat a heart condition caused by stress among people suffering from st...

Study suggests efficacy of MDD therapy linked to glucose metabolism

Researchers at Emory University reported data from an open-label trial examining brain glucose metabolism in major depressive disorder (MDD) patients receiving generic escitalopram or cognitive behavi...

Effect of Escitalopram on Mental Stress–Induced Myocardial Ischemia Results of the REMIT Trial Escitalopram and Stress-Induced Myocardial Ischemia

ImportanceMental stress can induce myocardial ischemia and also has been implicated in triggering cardiac events. However, pharmacological interventions aimed at reducing mental stress–induced myoca...

CBT preferred over drug therapy for social anxiety disorder

Adults with social anxiety disorder should only be offered pharmacological treatment (escitalopram or sertraline) once the option of cognitive behavioural therapy (CBT) has been offered, explored and...

Escitalopram: Data

P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents

The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings

P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-like Activity of Escitalopram in Rodents.

Despite the clinical prevalence of the antidepressant escitalopram, over 30% of escitalopram-treated patients fail to respond to treatment. Recent gene association studies have highlighted a potential...

Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.

The aim of this proof-of-concept study was to compare the efficacy of escitalopram (20 mg/d) in combination with fixed doses of gaboxadol to escitalopram (20 mg) in the treatment of patients with seve...

No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression.

Inflammation may contribute to the pathogenesis of depression and antidepressants are hypothesised to have an anti-inflammatory effect. In this randomised double-blinded trial we investigated the cyto...

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study.

ABSTRACTBackground: Antipsychotics are frequently used to treat psychosis, aggression and agitation in patients with Alzheimer's disease (AD), but safety warnings abound. Escitalopram was investigated...

Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter-a review of current understanding of its mechanism of action.

RATIONALE: Escitalopram is a widely used antidepressant for the treatment of patients with major depression. It is the pure S-enantiomer of racemic citalopram. Several clinical trials and meta-analyse...